G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 97 filers reported holding G1 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $415,102 | -48.0% | 288,265 | -10.0% | 0.00% | – |
| Q2 2023 | $797,661 | -50.7% | 320,346 | -46.9% | 0.00% | – |
| Q1 2023 | $1,617,161 | +16.2% | 603,418 | +135.4% | 0.00% | – |
| Q4 2022 | $1,392,067 | -66.8% | 256,366 | -23.7% | 0.00% | -100.0% |
| Q3 2022 | $4,196,000 | +233.0% | 335,954 | +31.7% | 0.00% | – |
| Q2 2022 | $1,260,000 | -54.3% | 255,053 | -29.7% | 0.00% | – |
| Q1 2022 | $2,756,000 | -27.5% | 362,573 | -2.7% | 0.00% | – |
| Q4 2021 | $3,804,000 | +3.7% | 372,700 | +36.3% | 0.00% | – |
| Q3 2021 | $3,669,000 | -51.1% | 273,365 | -20.0% | 0.00% | -100.0% |
| Q2 2021 | $7,496,000 | +14.9% | 341,638 | +26.0% | 0.00% | 0.0% |
| Q1 2021 | $6,523,000 | +35.6% | 271,138 | +1.4% | 0.00% | 0.0% |
| Q4 2020 | $4,809,000 | +46.3% | 267,314 | -6.0% | 0.00% | – |
| Q3 2020 | $3,286,000 | -49.2% | 284,476 | +6.7% | 0.00% | -100.0% |
| Q2 2020 | $6,466,000 | +123.4% | 266,549 | +1.5% | 0.00% | 0.0% |
| Q1 2020 | $2,894,000 | -59.7% | 262,577 | -3.4% | 0.00% | 0.0% |
| Q4 2019 | $7,183,000 | +15.8% | 271,796 | -0.2% | 0.00% | 0.0% |
| Q3 2019 | $6,203,000 | -32.5% | 272,337 | -9.1% | 0.00% | 0.0% |
| Q2 2019 | $9,188,000 | +24.1% | 299,649 | -32.8% | 0.00% | 0.0% |
| Q1 2019 | $7,404,000 | +52.5% | 445,977 | +75.9% | 0.00% | 0.0% |
| Q4 2018 | $4,855,000 | -63.3% | 253,579 | +0.1% | 0.00% | -50.0% |
| Q3 2018 | $13,245,000 | +13.9% | 253,298 | -5.3% | 0.00% | 0.0% |
| Q2 2018 | $11,624,000 | +22.7% | 267,471 | +4.6% | 0.00% | 0.0% |
| Q1 2018 | $9,470,000 | +86.9% | 255,594 | +0.1% | 0.00% | +100.0% |
| Q4 2017 | $5,066,000 | +56188.9% | 255,376 | +69866.0% | 0.00% | – |
| Q3 2017 | $9,000 | – | 365 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |